Company / R&D Expense
Sanara MedTech Inc. R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.8M
FY2025
5-year range
$40.2K / $4.1M
FY2021-FY2025
Trend
-31.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 3-year CAGR of +71.7%.
Declined from $3M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +71.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +71.7%, indicating consistent growth.
- In FY2025, r&d expense decreased 31.5% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8M | -31.5% |
| FY2024 | $4.1M | +22.7% |
| FY2023 | $3.4M | +502.7% |
| FY2022 | $558.7K | +1290.2% |
| FY2021 | $40.2K | - |
| FY2020 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026